NCT03247374

Brief Summary

The primary purpose of the study is to evaluate whether the effect of bio-feedback dysphagia treatment is more effective than a control treatment in post-stroke patients. This study will be a randomized, single-blind controlled pilot study. The investigators intend to recruit 40 patients who have suffered a stroke and have dysphagia. Twenty patients will undergo training with bio-feedback (experimental group) and the other 20 patients will undergo standard training, using only verbal feedback rather than visual feedback (control group). The authors hypothesize that in the control group the efficacy of the treatment will be lower in the absence of immediate visual feedback of strength and coordination of the swallowing act.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
17

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 20, 2017

Completed
22 days until next milestone

First Posted

Study publicly available on registry

August 11, 2017

Completed
7 months until next milestone

Study Start

First participant enrolled

February 27, 2018

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2020

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

October 4, 2022

Completed
Last Updated

October 5, 2022

Status Verified

October 1, 2022

Enrollment Period

2.6 years

First QC Date

July 20, 2017

Last Update Submit

October 4, 2022

Conditions

Keywords

rehabilitationtreatmentbiofeedbackbio-feedbackdysphagiaswallowing disorderspost-strokedeglutition disorders

Outcome Measures

Primary Outcomes (1)

  • Change in Functional Oral Intake Scale (FOIS)

    It is a 7-point scale developed to systematically rate the functional severity of dysphagia

    Baseline , 4 weeks , finally after 3 months from the end of treatment

Secondary Outcomes (2)

  • Change in Pooling Score (P-score)

    Baseline , 4 weeks , finally after 3 months from the end of treatment

  • Change in Penetration-Aspiration Scale (PAS)

    Baseline , 4 weeks , finally after 3 months from the end of treatment

Study Arms (2)

"ProComp5 Infiniti" Biofeedback

EXPERIMENTAL

Each participant will attend 5 sessions per week for a total duration of 5 weeks. The duration of each session will take 1 hour, including bio-feedback preparation. At the beginning of the bio-feedback session, a surface electrode will be applied to the mylohyoid muscle. The patient will be required to swallow at a given time, with food bolus if possible, and perform maneuvers that favour swallowing strength and efficacy: effortful swallow, supraglottic swallow, and "Masako" maneuver, the first two with bolus administration, if possible. The experimental group will perform this training for 45 minutes, plus they will receive a verbal feedback from the speech and language therapist.

Device: "ProComp5 Infiniti" Biofeedback

Standard Speech and Language Therapy

ACTIVE COMPARATOR

Each participant will attend 5 sessions per week for a total duration of 5 weeks. The patient will be required to swallow at a given time, with food bolus if possible, and perform maneuvers that favour swallowing strength and efficacy: effortful swallow, supraglottic swallow, and "Masako" maneuver, the first two with bolus administration, if possible. The control group will attend this training for 45 minutes, receiving verbal feedback from the speech and language therapist.

Other: Standard Speech and Language Therapy

Interventions

Each participant will attend 5 sessions per week for a total duration of 5 weeks. At the beginning of the bio-feedback session, a surface electrode will be applied to the mylohyoid muscle. The computer will produce visual feedback of the muscular activity on the screen. The patient will be required to swallow at a given time, with food bolus if possible, and perform maneuvers that favour swallowing strength and efficacy: they are requested to do classical maneuvers that favour swallowing efficacy that is effortful swallow, supraglottic swallow, and "Masako" maneuver. The experimental group will perform this training for 45 minutes.

"ProComp5 Infiniti" Biofeedback

Each participant will attend 5 sessions per week for a total duration of 5 weeks. The patient will be required to swallow at a given time, with food bolus if possible, and perform maneuvers that favour swallowing strength and efficacy receiving verbal feedback from the speech and language therapist. They are requested to do classical maneuvers that favour swallowing efficacy that is effortful swallow, supraglottic swallow, and "Masako" maneuver. The control group will perform this training for 45 minutes.

Standard Speech and Language Therapy

Eligibility Criteria

Age18 Years - 81 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • first stroke injury
  • single lesion
  • onset from more than six weeks
  • presence of dysphagia (Dysphagia Outcome and Severity Scale ≥ 4)
  • good comprehension ( not below PT 53 in Token Test)
  • good eyesight and hearing, or adequately corrected

You may not qualify if:

  • All the elements that hinder a good recording of the electromyographic signal (for instance a cutaneous infection, a wound or a dermatitis in the submandibular area);
  • Severe concomitant illnesses (fever, infections, metabolic problems, serious cardiac insufficiency) that can influence patient's collaboration;
  • Serious dystonia or unintentional movements
  • presence of disorders of consciousness;
  • encephalopathy due to multiple infarcts;
  • inability to sustain the experimental treatment;
  • other neurological diseases (for example Parkinson disease);

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sara Nordio

Venice-Lido, Italy

Location

MeSH Terms

Conditions

Deglutition Disorders

Interventions

Language Therapy

Condition Hierarchy (Ancestors)

Esophageal DiseasesGastrointestinal DiseasesDigestive System DiseasesPharyngeal DiseasesOtorhinolaryngologic Diseases

Intervention Hierarchy (Ancestors)

Rehabilitation of Speech and Language DisordersRehabilitationAftercareContinuity of Patient CarePatient CareTherapeutics

Study Officials

  • Sara Nordio

    IRCCS San Camillo

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: simple randomization into two groups
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Speech and language therapist

Study Record Dates

First Submitted

July 20, 2017

First Posted

August 11, 2017

Study Start

February 27, 2018

Primary Completion

October 1, 2020

Study Completion

October 4, 2022

Last Updated

October 5, 2022

Record last verified: 2022-10

Locations